Term Sheet Amneal Pharmaceuticals, Inc.Term Sheet • October 18th, 2023 • Patel Gautam • Pharmaceutical preparations • Delaware
This Term Sheet (the “Term Sheet”) is entered into as of October 16, 2023, by and among Amneal Pharmaceuticals, Inc., a Delaware corporation (“Old PubCo”), Amneal Pharmaceuticals LLC (“Opco”) and, solely for purposes of the Amneal Group Representative Consent (as defined below), the Amneal Group Representative1, on behalf of the Amneal Legacy Group. Each of Old PubCo and Opco may be referred to herein as a “Party” and collectively as the “Parties”.
Securities Account Sole Control AgreementSecurities Account Sole Control Agreement • August 26th, 2019 • Patel Gautam • Pharmaceutical preparations • New York
Account Holder/Debtor: Falcon Trust (“Debtor”) Address: Sierra Fiduciary Support Services 100 West Liberty Way, 10th floor Reno, Nevada 89501 Telephone: 775-326-4371 Email: rarmstrong@mcdonaldcarano.com Attention: Robert Armstrong
Amneal Pharmaceuticals, Inc. Amneal Pharmaceuticals LLCPromissory Note and Collateral Agreement • August 26th, 2019 • Patel Gautam • Pharmaceutical preparations • New York
This letter agreement (this “Letter Agreement”) is to confirm the mutual understanding among Credit Suisse AG, acting through its New York Branch (the “Lender”), Amneal Pharmaceuticals LLC (the “Company”), Amneal Pharmaceuticals, Inc. (“Amneal”) and Falcon Trust (the “Borrower”) with respect to the pledge (the “Pledge”) by the Borrower to the Lender (itself or through one of its affiliates, any such affiliate being treated as the Lender for purposes of this Letter Agreement) of, initially, 15,221,537 Units of the Company (the “Units”) and an equal number of shares of Class B Common Stock of Amneal (the “Class B Shares”), in each case pursuant to a Promissory Note and Collateral Agreement dated as of May 15, 2019 between the Borrower and the Lender (as amended, supplemented or modified from time to time, the “Loan Agreement”) and certain transactions related thereto. The Pledge will be made in favor of the Lender (the Units and Class B Shares that are so pledged at any time, the “Pledge
FINANCIAL ASSETS SECURITY AGREEMENTFinancial Assets Security Agreement • August 26th, 2019 • Patel Gautam • Pharmaceutical preparations • New York
FINANCIAL ASSETS SECURITY AGREEMENT, dated as of May 13, 2019 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), made by THE T-TWELVE LEGACY TRUST DATED DECEMBER 8, 2006, an irrevocable Nevada trust (the “Grantor”), to MORGAN STANLEY PRIVATE BANK, NATIONAL ASSOCIATION, a national banking association (together with its successors and assigns, the “Lender”).
ACKNOWLEDGMENT AND AGREEMENTAcknowledgment and Agreement • August 26th, 2019 • Patel Gautam • Pharmaceutical preparations • New York
This Acknowledgment and Agreement (this “Agreement”) is made as of May 13, 2019, by and among THE T-TWELVE LEGACY TRUST DATED DECEMBER 8, 2006, an irrevocable Nevada trust (“Pledgor”), AMNEAL PHARMACEUTICALS LLC, a Delaware limited liability corporation (the “LLC”), AMNEAL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and MORGAN STANLEY PRIVATE BANK, NATIONAL ASSOCIATION (“Lender”).
